Background: It is difficult to distinguish atypical cancerous nodule from cirrhosis nodule. Purpose: To investigate the value of spectral computed tomography (CT) imaging parameters in differentiating hepatic cancerous nodules from cirrhosis nodules. Material and Methods: Forty-six patients with hepatic nodules underwent contrast-enhanced CT scans in spectral mode. Monochromatic CT images and iodine/water-based material-decomposition images were synthesized. CT values were measured at 70 keV monochromatic images and the difference of CT value in the arterial phase (AP) and delayed phase (DP) (᭝CT1); AP and portal venous phase (PP) (᭝CT2) were calculated. Normalized to the iodine concentration in the aorta (NIC), lesion to normal liver parenchyma iodine concentration ratio (LNR) was calculated. Slope of the spectral HU curve (kHU) was obtained. Intraclass correlation coefficient (ICC) was used for consistency test. Receiver operating characteristic (ROC) curves were also generated. Results: There were 23 hepatic cancerous nodules and 23 cirrhosis nodules. All gemstone spectral imaging (GSI) parameters had significantly larger value in cancerous nodules than in cirrhosis nodules, except NIC in DP. The LNR in AP had the largest area under the curve (AUC) of 0.96, indicating its highest ability to differentiate hepatic cancerous nodules from cirrhosis nodules. Using 1.99 as a threshold value for LNR in AP we could obtain sensitivity of 95.65% and specificity of 91.30%. Conclusion: We have demonstrated in this feasibility study that spectral CT imaging provides multiple quantitative parameters which may be used to help differentiating hepatic cancerous nodules from cirrhosis nodules.
Introduction
Hepatocellular carcinoma (HCC) is the third main cause of cancer-related deaths worldwide (1) . HCC usually occurs in cirrhotic livers (2) ; the treatments for cancerous nodule and cirrhosis nodule are of great difference (3) . Therefore, it is vital to distinguish cancerous nodule from cirrhosis nodule. The imaging features of HCC could be very complicated. Nowadays, a new equipment called spectral computed tomography (CT) not only has the ability to enhance image quality (4) and improve lesion detection (5, 6) , but also can provide a number of quantitative parameters helping diagnose the disease. The gemstone spectral imaging (GSI) system could provide material decomposition images, through which we can measure lesions in terms of iodine concentration and water concentration (7) (8) (9) . The virtual spectral curves (VSCs) can reflect the X-ray attenuation coefficient of the tissue at different energy levels (10) . The aim of our study was to investigate the feasibility of using quantitative parameters obtained from GSI system to discern hepatic cancerous nodules from cirrhosis nodules.
Material and Methods
This study was approved by our hospital and written informed consent was obtained from each patient. From October 2015 to February 2017, 46 patients who underwent upper-abdominal contrast-enhanced three-phase CT scanning were prospectively enrolled. All of the patients (11 women, 35 men; age range ¼ 18-68; mean age ¼ 46 AE 6.l years) had following resection or biopsy of hepatic nodules.
CT examination
All patients underwent CT examinations on a Discovery CT750 HD system (GE Healthcare, Milwaukee, WI, USA) with the GSI mode. The CT scanning parameters were: tube current ¼ 630 mA; rotation speed ¼ 0.6 s; detector coverage ¼ 40 mm; helical pitch ¼ 1.375:1; helical thickness and interval for axial images ¼ 5 mm/5 mm. The contrast medium Iohexol (Omnipaque; GE Healthcare, USA) was injected by power injector at a dose of 1.5 mL/kg and a rate of 3.5 mL/s through median cubital vein. For the arterial phase, portal venous phase, and delayed phase, scanning started 35, 67, and 135 s after the beginning of contrast injection, respectively (11) .
Data analysis
The CT value of the lesions was measured using the virtual monochromatic image sets and the iodine concentration (IC) and water concentration (WC) were measured using the iodine and water-based material decomposition images, respectively (Figs. 1 and 2). Two observers performed the region of interest (ROI) measurements manually and independently. The ROIs were first selected using the 70 keV virtual monochromatic images in the image slice containing lesions with the largest diameter to measure CT values. The ROIs were as large as possible to reduce noise (12) . ROIs were also placed centered on the aorta and on normal liver tissues that were close to hepatic nodules. These measurements were used for normalizing the iodine concentration (NIC) measurements and calculating lesion to normal liver parenchyma iodine concentration ratio (LNR) for hepatic nodules. For each patient, the ROI selections were then propagated to monochromatic images of different energies (40-140 keV) to measure CT value as function of photon energy and to the material decomposition image pairs of iodine-water to measure material concentrations. The propagation was performed using the copy-and-paste function to keep the size, shape, and position of ROIs identical in different image types. All the measurements were performed again by Observer 1 two weeks after the first measurement to calculate the intra-observer variation. ROIs were 46.0 AE 30.2 mm 2 (range ¼ 18-128 mm 2 ) for the cirrhosis nodules and 101.0 AE 56.8 mm 2 (range ¼ 24-165 mm 2 ) for the cancerous nodules. The smallest lesion was 1.5 cm in size and the largest was 2.8 cm. The ROI was placed avoiding hemorrhage, necrosis, or a cystic region. These measurements were performed on the arterial phase, portal venous phase, and delayed phase. The IC value of hepatic lesion was normalized to that of abdominal aorta in the same slice to obtain the normalized iodine concentration (NIC): NIC ¼ IC lesion /IC aorta . The IC in the lesion and in the normal hepatic were measured to generate the lesion to normal liver parenchyma iodine concentration ratio (LNR): LNR ¼ IC lesion /IC liver . These NIC values were generated to reduce the impact of different cardiac outputs of different patients. From the CT value as function of photon energy measurement (spectral HU curve), the slope of spectral HU curve was also calculated as: kHU ¼|CT 40keV -CT 140keV |/100. Moreover, ᭝CT1 was defined as the CT number of AP minus the CT number of the DP; ᭝CT2 was defined as the CT number of AP minus the CT number of the PP.
Statistical analysis
The two-sample t-test was used to compare these parameters between cancerous nodules and cirrhosis nodules, and ANOVA was used to compare these parameters in AP, PP, and DP for cancerous nodules and cirrhosis nodules. Statistical analysis was performed using SPSS for Windows (IBM SPSS Statistics 22.0, Armonk, NY, USA) and MedCalc (MedCalc 13.0, Mariakerke, Belgium). Results were considered statistically significant if P < 0.05. Intraclass correlation coefficient (ICC) was used for consistency test. ICC values were categorized into five categories: ! 0.81 ¼ excellent; 0.61-0.80 ¼ good; 0.41-0.61 ¼ moderate; 0.21-0.40 ¼ fair; and 0.0-0.20 ¼ poor (13) . Receiver operating characteristic curve (ROC) was generated to determine the optimal threshold values to distinguish hepatic cancerous nodules from cirrhosis nodules, and the sensitivity and specificity were calculated. The diagnostic capability was represented by the area under the ROC curve (AUC).
Results

Radiation dose
The volumetric CT dose index (CTDIvol) and the doselength product (DLP) values were recorded from PACS. The DLP value was 297.77 AE 25.27 mGyÁcm and a fixed value of 13.79 AE 2.35 mGy for CTDIvol for each phase.
Quantitative analyses
ICC for the measurements of GSI parameters values indicated excellent intra-observer and inter-observer consistency ( Table 1) .
Quantitative GSI measurements of the cancerous nodules and cirrhosis nodules are listed in Table 2 . LNR, kHU, and WC for cancerous nodules were greater than cirrhosis nodules in all three phases. LNR and NIC in the arterial phase had an obvious difference in distinguishing cancerous nodules from cirrhosis nodules. NIC in DP, LNR in PP, and DP did not have statistically significant difference. ROC curves were used to find out about the capacity of different parameters-CT value, NIC, WC, LNR, and kHU-in discerning cancerous nodules and cirrhosis nodules. The results showed that LNR in AP had the largest AUC of 0.96, indicating the highest differentiating performance ( Fig. 3) . The sensitivity and specificity of LNR in AP were 95.65% and 91.30%, respectively, with a threshold of 1.99. The diagnostic specificity and sensitivity values were listed in Table 3 . The WC in DP, NIC in AP, and kHU in DP had relatively high sensitivity and specificity. Other parameters also help to diagnose the hepatic nodules to a certain extent.
Qualitative analyses
Qualitative analysis showed that 18/23 (78.26%) cancerous nodules and 12/23 (52.17%) cirrhosis nodules were in the right lobe. Of the cancerous nodules, 65.22% were in irregular shapes, whereas 52.17% of cirrhosis nodules were in regular shapes. None of the lesions had circumferential enhancement. All 23 cancerous nodules showed enhancement in the arterial phase, while there were nine (39.13%) cirrhosis nodules showing enhancement in the arterial phase. Washout was found in 10/23 (43.48%) cancerous nodules and none of the 23 cirrhosis nodules. The expansion of enhancement regions between AP and PP was found in 15 (65.22%) of the cancerous nodules and 18 (78.26%) of the cirrhosis nodules.
Dual-energy CT imaging characteristics
The GSI parameters included NIC, WC, LNR, and kHU between cancerous nodules and cirrhosis nodules in all phases and ᭝CT1 and ᭝CT2. NIC results showed that the IC in cancerous nodules was much greater than cirrhosis nodules in AP (t ¼ 5.200, P < 0.05) and PP (t ¼ 3.594, P < 0.05). Moreover, kHU, WC, and LNR of cancerous nodules was significantly higher than cirrhosis nodules in all phases: kHU, AP: t ¼ 4.297, P ¼ 0.000; PP: t ¼ 2.796, P ¼ 0.011; DP: t ¼ 6.107, P ¼ 0.000; WC, AP: t ¼ 2.636, P ¼ 0.015; PP: t ¼ 1.611, P ¼ 0.012; DP: t ¼ 1.990, P ¼ 0.048; LNR; AP: t ¼ 6.110, P ¼ 0.000; PP: t ¼1.530, P ¼ 0.140; DP: t ¼ 1.515, P ¼ 0.240.
There were also parameters which did not show significant difference between cancerous nodules and cirrhosis nodules: NIC in DP (t ¼ À1.045, P ¼ 0.307), LNR in PP (t ¼ 1.530, P ¼ 0.140) and DP (t ¼ 1.515, P ¼ 0.240), and ᭝CT2 (t ¼ 1.221, P ¼ 0.919).
Discussion
Contrast-enhanced CT and magnetic resonance (MR) are the most widely used imaging approaches in the diagnoses of liver tumors (14) . Multiphase contrast enhancement could reflect the hemodynamic characteristics of the lesion (10). However, HCC always develops in cirrhotic livers (3) . Some types of liver malignancies were evolved from cirrhosis nodules, so it is important to discover cancerous nodules in the early stage as well to distinguish hepatic cancerous nodules from cirrhosis nodules.
Dual-energy CT (DECT) can reflect material and spectral tissue characterization (15) . Material decomposition images provide the IC and WC of hepatic nodules. In the development of a neoplasm, angiogenesis is an important process (16) . The appearance of obvious enhancement of malignant neoplasms on MR imaging (MRI) (17) and CT (8, 18, 19) relied on the abundant angiogenesis of malignant neoplasms than benign nodules. To reach medical standards, iodine and water are usually chosen as the most common basis pair for medical decomposition image exhibition due to their numbers across the range of atomic numbers for materials generally used in medical imaging and iodinated contrast material to lead to material-attenuation images that are easy to understand (20) . IC in nodules can reflect the blood supply of the lesion, while WC can evaluate the degree of fibrosis. To our knowledge, our research was the first to study the value of spectral CT to qualitatively and quantitatively analyze the HCC and cirrhosis nodules by using multiple parameters. We aimed to use multiparameters (᭝CT1, ᭝CT2, NIC, LNR, kHU) in the dual-energy spectral CT to differentiate hepatic cancerous from cirrhosis nodules. Our study showed that LNR in AP had the greatest ability to differentiate hepatic cancerous nodules from cirrhosis nodules. Both studies showed that spectral CT could be used as a useful equipment to diagnose HCC.
The analysis displayed that there were significant differences between hepatic cancerous nodules and cirrhosis nodules in NIC (both AP and PP), LNR (AP), ᭝CT1, WC, and kHU (in all phases). These data implied that some of the parameters could be used as a quantitative standard to different hepatic cancerous nodules from cirrhosis nodules.
The NIC and LNR in AP and NIC in PP of cancerous nodules were higher than cirrhosis nodules; we predicted that the rich blood supply and atypical of cancerous nodules lead to this phenomenon. The WC in all phases of cancerous nodules were higher than cirrhosis nodules; this may be related to cirrhosis nodules when evolving from hepatic fibrosis, so the water content was less than cancerous nodules. Our research also indicated that kHU of cancerous nodules in all phases were much greater than cirrhosis nodules, and at the same time had relatively high sensitivity and specificity. There are several ways to perform DECT. Even though the methods of analyzing the two energy spectrums are different, all dual-energy systems generate two types of images: virtual monochromatic image sets and material decomposition images. These were the two types of images used in our study and they provided more information than the conventional CT that has only CT value and improved the accuracy of differentiating hepatic cancerous nodules from cirrhosis nodules. On the other hand, different approaches would have different image artifacts associated with the way images were generated and different energy separations and thus different image noise even through the radiation dose might be the same. This would impact the sensitivity and specificity when differentiating hepatic cancerous nodules from cirrhosis nodules. Of course, the exact amount needs further research.
In our research, we followed the contrast media policy of a previous study (11) and started the threephase scans using fixed delay times. In our study, the radiation dose (CTDI value) for the spectral CT mode was 13.79 AE 2.35 mGy, which was similar or even lower than the conventional CT scans in the same anatomic area and for patients with similar sizes. Spectral CT scans followed the same clinical workflow as the conventional single tube voltage CT scans. Reconstruction for the entire abdominal CT scans took about 2 min and the spectral CT images were analyzed using dedicated GSI software that were reasonably fast.
Our study did have some limitations. First, this study contained a small number of patients; further study with more patients is needed. Second, due to the GSI software for analyzing the spectral CT images, our system did not have the capability to perform the full three-dimensional (3D) analysis. Therefore, we performed the more commonly used two-dimensional ROI analysis in our study. We will incorporate the 3D analysis in our future study. Third, even though in our study we invited two radiologists (21) to decide where to put the ROI, there was still an unavoidable small difference. Fourth, only a few patients had the MRI examination, so it is difficult to get more information about the hepatic nodules. In the future, once more MRI examinations are performed, it is potentially feasible to explore the improvement of sensitivity and specificity when MRI features are added.
In conclusion, we have demonstrated in this feasibility study that CT spectral imaging provides multiple quantitative parameters which may be used to help differentiate hepatic cancerous nodules from cirrhosis nodules.
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